REFERENCES
- Brandes A., Soesan M., Fiorentino M. Medical Treatment in High Grade Malignant Gliomas in Adults: An Overview. Anticancer Res. 1991; 11: 719–728
- Hryniuk W. The Importance of Dose Intensity in the Outcome of Chemotherapy. Important Advances in Oncology, V. De Vita, S. Hellmann, S. Rosemberg. Lippincott, Philadelphia, PA 1989; 121–141
- Frei E., George M., Canellos P., et al. Dose: Critical Factor in Cancer Chemotherapy. Am. J. Med. 1980; 69: 585–593
- Cetto G., Molino A. Evoluzione del Concetto di Dose in Chemioterapia: Basi Teoriche E Modelli Matematici. Prog. Oncol. Clin. 1995; 4: 11–22
- Schabel F. Nitrosoureas: A Review of Experimental Antitumor Activity. Cancer Treat. Rep. 1976; 60: 665–697
- Kornblith P., Szypko P. Variations in Response of Human Brain Tumors to BCNU In Vitro. J. Neurosurg. 1978; 48: 580–586
- Deisseroth A., Abrams R. The Role of Autologous Stem Cell Reconstitution in Intensive Therapy for Resistant Neoplasm. Cancer Treat. Rep. 1979; 63: 461–471
- Johnson D., Thompson J., Corwin J., et al. Prolongation of Survival for High-Grade Malignant Gliomas with Adjuvant High-Dose BCNU and Autologous Bone Marrow Transplantation. J. Clin. Oncol. 1987; 5(5)783–789
- Mbidde E., Selby J., Perren T., et al. High Dose BCNU Chemotherapy with Autologous Bone Marrow Transplantation and Full Dose Radiotherapy for Grade IV Astrocytoma. Br. J. Cancer 1988; 58: 779–782
- Phillips G., Wolff S., Fay J., et al. Intensive 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) Monochemotherapy and Autologous Marrow Transplantation for Malignant Glioma. J. Clin. Oncol. 1986; 4(5)639–645
- Wolff S., Phillips G., Herzig G., et al. High-Dose of Carmustine with Autologous Bone Marrow Transplantation for the Adjuvant Treatment of High-Grade Gliomas of the Central Nervous System. Cancer Treat. Rep. 1987; 71: 183–185
- Linassier C., Calais G., Benboubker L., et al. Post-Operative High Dose BCNU Followed by Autologous Bone Marrow Transplantation and Radiotherapy in Newly Diagnostic High-Grade Astrocytomas. Proc. Am. Soc. Clin. Oncol. 1995; 14: 285, (Abstract)
- Fernandez-Hidalgo O., Vanaclocha V., Vieitez J., et al. High-Dose BCNU and Autologous Progenitor Cell Transplantation Given with Intra-Arterial Cisplatin and Simultaneous Radiotherapy in the Treatment of High-Grade Gliomas: Benefit for Selected Patients. Bone Marrow Transplant. 1996; 1(18)143–149
- Ascensao J., Ahmed T., Feldman E., et al. High-Dose Thiotepa with Autologous Bone Marrow Transplantation (ABMT) and Localized Radiotherapy for Patients with Astrocytoma Grado III/IV (glioma): A Promising Approach. Proc. Am. Soc. Clin. Oncol. 1989; 8: 90, (Abstract)
- Carella A., Giordano D., Santini G., et al. High Dose BCNU Followed by Autologous Bone Marrow Infusion in Glioblastoma Multiforme. Tumori. 1981; 67: 473–475
- Takvorian T., Parker L., Hochberg F., et al. Autologous Bone Marrow Transplantation: Host Effects of High-Dose BCNU. J. Clin. Oncol. 1983; 1(10)610–620
- Fingert H., Hochberg F. Megadose Chemotherapy with Bone Marrow Rescue. Prog. Exp. Tumor Res. 1984; 28: 67–78
- Hochberg F., Parker L., Takvorian T., et al. High Dose BCNU with Autologous Bone Marrow Rescue for Recurrent Glioblastoma Multiforme. J. Neurosurg. 1981; 54: 455–460
- Mortimer J., Hewlett J., Bay J., et al. High Dose BCNU with Autologous Bone Marrow Rescue for Recurrent Malignant Gliomas. Neurosurg. Rev. 1984; 7: 13–22
- Giannone L., Wolff S. Phase II Treatment of Central Nervous System Gliomas with High-Dose Etoposide and Autologous Bone Marrow Transplantation. Cancer Treat. Rep. 1987; 71: 759–761
- Nomura K., Watanabe T., Nekama O., et al. Intensive Chemotherapy with Autologous Bone Marrow Rescue for Recurrent Malignant Gliomas. Neurosurg. Rev. 1984; 7: 13–22
- Kanj S., Sharara A., Shpalla E., et al. Myocardial Ischemia Associated with High-Dose Carmustine Infusion. Cancer 1991; 68: 1910–1912
- Leff R., Thompson J., Daly M., et al. Acute Neurologic Dysfunction after High-Dose Etoposide Therapy for Malignant Glioma. Cancer 1988; 62: 32–35
- Ghosh C., Lazarus H., Hewlwtt J., et al. Fluctuation of Serum Phentoin Concentrations During Autologous Bone Marrow Transplantation for Primary Central Nervous System Tumors. J. Neuro-Oncol. 1992; 12: 25–32